The short answer
Endotoxin is a bacterial cell wall component that triggers biological responses at very low concentrations. It is not a protein, so it appears in no peptide purity figure and requires its own assay, which can itself under-report through a phenomenon called low endotoxin recovery.
Key facts
- What it is
- Bacterial cell wall lipopolysaccharide
- Appears in purity figure
- No (not a protein)
- Standard assay
- Limulus amebocyte lysate (LAL)
- Most relevant to
- Recombinant products from bacteria
- Complication
- Low endotoxin recovery (LER)
- LER mechanism
- Micellar aggregation (Schromm 2024)
Why it is a separate category of contaminant
Endotoxin is lipopolysaccharide from the outer membrane of Gram-negative bacteria. It is not a peptide, not a protein and not a synthesis by-product, so no HPLC purity figure and no mass spectrum accounts for it. A preparation can be 99% pure by every peptide measure and carry biologically significant endotoxin.
Why the quantities that matter are so small
The mammalian innate immune system evolved to detect bacterial invasion at the earliest possible moment, so it responds to lipopolysaccharide at extremely low concentrations. That sensitivity is the reason endotoxin limits are set far below where most contaminants would be considered relevant. The biology is tuned to notice trace amounts.
Research material referenced
BPC-157 5mg, third-party HPLC tested
Where it comes from
Chiefly from expression in bacterial systems, which makes it a recombinant-protein concern more than a synthetic-peptide one. Solid-phase chemical synthesis involves no bacteria. It can also enter through water, glassware or handling, which is why the assay applies more broadly than the production route alone would suggest.
How it is measured
The limulus amebocyte lysate assay, which uses a clotting cascade from horseshoe crab blood that is triggered by lipopolysaccharide. It is sensitive and long-established. Bolden and colleagues examined its performance in biologic drug products in the Journal of Pharmaceutical Science and Technology in 2014.
The complication called low endotoxin recovery
Endotoxin spiked into certain formulations becomes undetectable over time. The assay stops finding what is known to be present. Schromm and colleagues reported in Biomedicine and Pharmacotherapy in 2024 that supramolecular assembly into micellar aggregates underlies this, and that a whole-blood approach can resolve it. Lipopolysaccharide is amphipathic and self-associates, and once sequestered into aggregates it is no longer available to trigger the assay.
Why that is worth knowing
Because it means a negative result is not automatically an absence. The assay reports what it can access, and formulation components can make endotoxin inaccessible without removing it. This is the same general lesson as the impurities mass spectrometry cannot see: an analytical method answers the question it is capable of answering, and the limits belong with the result.
Frequently asked questions
Does a purity figure cover endotoxin?
No. Endotoxin is lipopolysaccharide, not a protein, so no peptide purity measure accounts for it. It needs its own assay.
Which products need endotoxin testing most?
Those expressed in bacterial systems. Chemical solid-phase synthesis involves no bacteria, though endotoxin can still enter through water or handling.
Continue researching
Related guides and reference material.
Primary sources & clinical trials
Published papers, trial registrations, regulator pages and company announcements. Links open the original.
- PubMedBolden JS et al., Evidence against a bacterial endotoxin masking effect in biologic drug products by LAL detection. PDA J Pharm Sci Technol 2014 (PMID 25336418)pubmed.ncbi.nlm.nih.gov
- PubMedSchromm AB et al., Supramolecular assembly of micellar aggregates is the basis of low endotoxin recovery. Biomed Pharmacother 2024 (PMID 38401515)pubmed.ncbi.nlm.nih.gov
- PubMedLi T et al., Production and characterization of highly purified recombinant thymosin beta 4. Protein Expr Purif 2013 (PMID 23711379)pubmed.ncbi.nlm.nih.gov
Browse the wider literature
Live database searches, not fixed citations. Results change as new work is indexed.
Written and published by UK Peptides, the trading name of AURYXRESEARCH LTD (company 17388727, registered in England and Wales).
Questions or a correction? Email hello@ukpeptides.org or call +44 7426 987848.
More Peptide Reference articles
- Peptides and Muscle Growth: Claims Against EvidenceThe compounds marketed for muscle growth work by different mechanisms, and most evidence measures hormones rather than muscle. What has actually been shown.
- Are Peptides Safe? It Depends Entirely on Which OneInsulin is a peptide. So is a compound with no human data at all. Safety is a property of the specific molecule and the specific material, not of the category.
- Are Peptides Steroids?No. Peptides are amino acid chains; steroids are built on a four-ring carbon skeleton. Different structures, different receptors, different regulation.
- Are Peptides Legal in the UK?Peptides are not one legal category. Most are not controlled drugs, most are not licensed medicines, and supply for human use is where the law actually bites.
- What Is a Peptide?A peptide is amino acids joined by peptide bonds. Where the boundary with proteins sits, why it is fuzzy, and what the bond actually is.